PSCR (Proto Script Pharmaceutical) Scaled Net Operating Assets: -6.43 (As of Sep. 2017)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Proto Script Pharmaceutical Scaled Net Operating Assets?

Proto Script Pharmaceutical PSCR Scaled Net Operating Assets is -6.43 as of Sep. 2017.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Proto Script Pharmaceutical's operating assets for the quarter that ended in Sep. 2017 was $0.24 Mil. Proto Script Pharmaceutical's operating liabilities for the quarter that ended in Sep. 2017 was $1.30 Mil. Proto Script Pharmaceutical's Total Assets for the quarter that ended in Jun. 2017 was $0.17 Mil. Therefore, Proto Script Pharmaceutical's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2017 was -6.43.


Proto Script Pharmaceutical Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Proto Script Pharmaceutical's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Proto Script Pharmaceutical Scaled Net Operating Assets Chart

Proto Script Pharmaceutical Annual Data
Trend May12 May13 May14 May15 May16
Scaled Net Operating Assets
-1.75 -1.75 -0.26 -3.21 -89.00

Proto Script Pharmaceutical Quarterly Data
Nov12 Feb13 May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Sep16 Dec16 Mar17 Jun17 Sep17
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -1.02 -4.78 -4.02 -6.43

PSCR vs EXCC, NXES, PRZM: Scaled Net Operating Assets Comparison

For the Specialty Business Services subindustry, Proto Script Pharmaceutical's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Proto Script Pharmaceutical Scaled Net Operating Assets vs Business Services Industry

For the Business Services industry and Industrials sector, Proto Script Pharmaceutical's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Proto Script Pharmaceutical's Scaled Net Operating Assets falls into.



Proto Script Pharmaceutical Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Proto Script Pharmaceutical's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in May. 2016 is calculated as

Scaled Net Operating Assets (SNOA)(A: May. 2016 )
=(Operating Assets (A: May. 2016 )-Operating Liabilities (A: May. 2016 ))/Total Assets (A: May. 2015 )
=(0-0.089)/0.001
=-89.00

where

Operating Assets(A: May. 2016 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0.012 - 0.012
=0

Operating Liabilities(A: May. 2016 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=0.089 - 0 - 0
=0.089

Proto Script Pharmaceutical's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2017 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Sep. 2017 )
=(Operating Assets (Q: Sep. 2017 )-Operating Liabilities (Q: Sep. 2017 ))/Total Assets (Q: Jun. 2017 )
=(0.235-1.303)/0.166
=-6.43

where

Operating Assets(Q: Sep. 2017 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0.235 - 0
=0.235

Operating Liabilities(Q: Sep. 2017 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=1.676 - 0 - 0.373
=1.303

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of -6.43 mean?
Proto Script Pharmaceutical (PSCR) has a Scaled Net Operating Assets of -6.43 as of Sep. 2017. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Proto Script Pharmaceutical and its competitors.
Is Proto Script Pharmaceutical's Scaled Net Operating Assets too high?
Proto Script Pharmaceutical's current Scaled Net Operating Assets is -6.43.
How does Proto Script Pharmaceutical's Scaled Net Operating Assets compare to EXCC and NXES?
Proto Script Pharmaceutical's Scaled Net Operating Assets of -6.43 can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Business Services company?
A good Scaled Net Operating Assets depends on the Business Services industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Proto Script Pharmaceutical and its competitors. Proto Script Pharmaceutical's current Scaled Net Operating Assets is -6.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Proto Script Pharmaceutical stock overvalued right now?
Proto Script Pharmaceutical (PSCR) has a current Scaled Net Operating Assets of -6.43. The current Scaled Net Operating Assets is -6.43. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Proto Script Pharmaceutical (PSCR), the current Scaled Net Operating Assets is -6.43 as of Sep. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Proto Script Pharmaceutical Business Description

Address 9830 6th Street, Suite 103, Rancho Cucamonga, CA, USA, 91730
Proto Script Pharmaceutical Corp is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. It has various contracts with state and governmental insurance providers, among others. These contracts provide the company with the right to sell and repair DME and its health care insurance contracts allow it the ability to service patients nationally. The group currently has its presence of repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California.